The cleavage of ACE2 by ADAM-17 (Haga et al., 2008, 2010; Scheller et al., 2011) is activated in SARS-CoV infection, generating sACE2 (Figure 7A). This evidence concerns the gene ADAM17 and severe acute respiratory syndrome.